Pilulka stock traded at CZK 900 per share at the end 2024 translating into a market capitalization of USD 40.1 mil. Since the end of 2019, the stock has appreciated by 0% representing an annual average growth of 0%.
At the end of 2024, the firm traded at price to earnings of 11.5x. Over the last five years, this multiple achieved a high of 91.1x in 2022 and a low of -73.4x in 2021 with an average of 6.56x.
Regarding cash generated defined by the sum of net profit and depreciation, the stock traded at 6.31x at the end of 2024. When investments are excluded to get free cash flow, Pilulka traded at 17.9x.
At the end of 2024, the company had a net debt of CZK -60.8 mil, or -0.414x of EBITDA and -20.6% of equity. The firm generated an average return on equity of -0.920% for its shareholders in the last five years and an average dividend yield of 0%.